AstraZeneca Pharma India Limited - Neraca (Quarterly)

AstraZeneca Pharma India Limited
IN ˙ NSEI ˙ INE203A01020
₹ 9,088.15 ↓ -1.55 (-0.02%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca AstraZeneca Pharma India Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
03-31
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
Cash 2,517 3,523 4,484 4,697 5,003 5,203 5,058 4,968 5,361
Change (%) 40.00 27.27 4.75 6.51 3.98 -2.77 -1.79 7.92
Assets Current 5,580 6,188 7,057 7,483 8,355 9,540 9,327 10,665 13,424
Change (%) 10.88 14.05 6.04 11.65 14.19 -2.23 14.35 25.86
Assets 7,202 7,747 8,566 8,964 9,849 11,016 10,780 12,413 15,181
Change (%) 7.57 10.57 4.65 9.88 11.85 -2.14 15.15 22.30
Liabilities 3,152 3,185 3,452 3,527 3,962 4,466 3,661 5,620 7,478
Change (%) 1.07 8.36 2.17 12.34 12.73 -18.02 53.49 33.07
Equity 4,050 4,562 5,114 5,437 5,887 6,550 7,119 6,794 7,704
Change (%) 12.63 12.11 6.31 8.28 11.26 8.70 -4.57 13.40
Liabilities And Stock Equity 7,202 7,747 8,566 8,964 9,849 11,016 10,780 12,413 15,181
Change (%) 7.57 10.57 4.65 9.88 11.85 -2.14 15.15 22.30

Source: Capital IQ

Other Listings
IN:506820
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista